NCT07195123NARecruiting

Evaluation of the SMART IBD App in Pediatric IBD

Children's Hospital Medical Center, Cincinnati

Start Date

10/23/2025

Completion Date

8/31/2027

Summary

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.

Eligibility Criteria

Age Range: 13 years to 17 years

Inclusion Criteria: * Confirmed diagnosis of IBD (Crohn's Disease, ulcerative colitis, or indeterminate colitis) * Prescribed at least one daily or weekly medication for treatment of IBD * \<86% adherence to prescribed medication * Access to internet via Wi-Fi or data plan and access to smartphone * English fluency for patient and caregiver Exclusion Criteria: * Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review * Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review

Interventions

BEHAVIORAL

SMART-IBD

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Inflammatory Bowel Disease (IBD)IBD (Inflammatory Bowel Disease)IBD - Inflammatory Bowel DiseaseUlcerative Colitis (UC)Indeterminate ColitisCrohn Disease (CD)IBD

Locations

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio 45229

United States